Tomáš Pika
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 51
- Multiple Myeloma Research and Treatments 50
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 20
- Protein Degradation and Inhibitors 12
- Co-authors
- Jiří Minařík (51 shared papers)Vlastimil Ščudla (22 shared papers)Jaroslav Bačovský (32 shared papers)Roman Hájek (20 shared papers)Petr Džubák (2 shared papers)Marián Hajdúch (2 shared papers)Kateřina Langová (8 shared papers)Christoph Kimmich (1 shared paper)
In The Last Decade
Tomáš Pika
54 papers receiving 328 citations
Peers
Comparison fields: 5 of 46
- Hematology 224
- Genetics 68
- Oncology 129
- Nephrology 31
- Molecular Biology 222
Countries citing papers authored by Tomáš Pika
This map shows the geographic impact of Tomáš Pika's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Pika with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Pika more than expected).
Fields of papers citing papers by Tomáš Pika
This network shows the impact of papers produced by Tomáš Pika. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Pika. The network helps show where Tomáš Pika may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomáš Pika, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 27 | |
| 2 | 2020 | 26 | |
| 3 | 2018 | 21 | |
| 4 | 2021 | 21 | |
| 5 | 2015 | 21 | |
| 6 | 2019 | 19 | |
| 7 | 2016 | 16 | |
| 8 | 2017 | 14 | |
| 9 | 2012 | 13 | |
| 10 | 2011 | 11 | |
| 11 | 2011 | 10 | |
| 12 | 2015 | 10 | |
| 13 | 2017 | 9 | |
| 14 | 2010 | 8 | |
| 15 | 2015 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2016 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2010 | 5 |
About Tomáš Pika
Tomáš Pika is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Neurology, having authored 67 papers that have together received 336 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (50 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (20 papers), Cancer Treatment and Pharmacology (12 papers), Protein Degradation and Inhibitors (12 papers), Peptidase Inhibition and Analysis (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Bone health and treatments (8 papers). The work is most often cited by research in Hematology (224 citations), Genetics (68 citations), Oncology (129 citations), Nephrology (31 citations) and Molecular Biology (222 citations). Tomáš Pika has collaborated with scholars based in Czechia, Greece and Spain. Frequent co-authors include Jiří Minařík, Vlastimil Ščudla, Jaroslav Bačovský, Roman Hájek, Petr Džubák, Marián Hajdúch, Kateřina Langová, Christoph Kimmich, Ute Hegenbart and Vladimír Maisnar. Their work appears in journals such as Blood, European Journal Of Haematology, Annals of Hematology, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.